Dr Schutz UK Limited Filleted accounts for Companies House (small and micro)

COMPANY REGISTRATION NUMBER: 5058747

Dr Schutz UK Limited

Filleted Financial Statements

31 December 2025

Dr Schutz UK Limited

Statement of Financial Position

31 December 2025

	2025		2024
Note	£	£	£

Fixed assets

Tangible assets	6		1,385	–

Current assets

Stocks		63,744	55,957
Debtors	7	73,968	163,005
Cash at bank and in hand		71,649	24,932
		--------	--------
		209,361	243,894

Creditors: amounts falling due within one year	8	255,286		215,344
		--------		--------
Net current (liabilities)/assets			( 45,925)	28,550
			-------	-------
Total assets less current liabilities			( 44,540)	28,550
			-------	-------
Net (liabilities)/assets			( 44,540)	28,550
			-------	-------

Capital and reserves

Called up share capital	200	200
Profit and loss account	( 44,740)	28,350
	-------	-------
Shareholders (deficit)/funds	( 44,540)	28,550
	-------	-------

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements were approved by the board of directors and authorised for issue on 27 March 2026 , and are signed on behalf of the board by:

Mr G White
Director

Company registration number: 5058747

Dr Schutz UK Limited

Notes to the Financial Statements

Year ended 31st December 2025

1. General information

The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 5-11 Mortimer Street, London, W1T 3HS.

2. Statement of compliance

These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.

3. Accounting policies

(a) Basis of preparation

The financial statements have been prepared on the historical cost basis. The financial statements are prepared in sterling, which is the functional currency of the entity.

(b) Going concern

The financial statements have been prepared on the going concern basis by the directors. The company had a loss for the year of £73,090 and at 31st December 2025 owed £209,243 to its holding company. It is dependent on its parent company not seeking repayment of this balance and providing ongoing support as needed to continue as a going concern. Whilst not being legally enforceable, the parent company has confirmed that it has sufficient resources and will continue to support the company as necessary for at least the next 18 months. The parent company has also converted the loan detailed in note 10 into share capital since the year end. As a result, the directors consider it appropriate to treat the company as a going concern.

(c) Revenue recognition

Turnover is measured at the fair value of the consideration receivable for goods supplied and services rendered, stated net of discounts and of Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer, usually on despatch of the goods. Revenue from services rendered is recognised by reference to the stage of completion of the transaction at the balance sheet date.

(d) Taxation

The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to be paid or recovered using the tax rates and laws that have been enacted or substantively enacted at the reporting date. Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.

(e) Foreign currencies

Foreign currency transactions are initially recorded in the functional currency, by applying the spot exchange rate as at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are translated at the exchange rate ruling at the reporting date, with any gains or losses being taken to the profit and loss account.

(f) Tangible assets

Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses.

(g) Depreciation

Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

	Equipment	-	25% straight line

(h) Stocks

Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stock to its present location and condition.

(i) Financial instruments

Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as either financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

(j) Defined contribution plans

Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided.

4. Corporation tax losses

The company has tax losses available of £132,723 (2024: £58,248) to utilise against future taxable profits.

5. Employee numbers

The average number of persons employed by the company during the year amounted to 3 (2024: 3 ).

6. Tangible assets

	Equipment	Total
	£	£
Cost
At 1st January 2025	1,377	1,377
Additions	1,746	1,746
	------	------
At 31st December 2025	3,123	3,123
	------	------
Depreciation
At 1st January 2025	1,377	1,377
Charge for the year	361	361
	------	------
At 31st December 2025	1,738	1,738
	------	------
Carrying amount
At 31st December 2025	1,385	1,385
	------	------
At 31st December 2024	–	–
	------	------

7. Debtors

	2025	2024
	£	£
Trade debtors	69,987	157,883
Other debtors	3,981	5,122
	-------	--------
	73,968	163,005
	-------	--------

8. Creditors: amounts falling due within one year

	2025	2024
	£	£
Trade creditors	11,983	44,830
Amounts owed to holding company	209,243	126,956
Social security and other taxes	21,424	9,701
Other creditors	12,636	33,857
	--------	--------
	255,286	215,344
	--------	--------

Amounts owed to holding company includes a loan of €35,000. The loan is unsecured and carries interest at 3.75% over the bank base interest rate of the United Kingdom. This loan has been converted into share capital in the company since the year end.

9. Operating leases

The total future minimum lease payments under non-cancellable operating leases are as follows:

	2025	2024
	£	£
Not later than 1 year	15,388	21,312
Later than 1 year and not later than 5 years	23,054	–
	-------	-------
	38,442	21,312
	-------	-------

10. Summary audit opinion

The auditor's report dated 30 March 2026 was unqualified .

The senior statutory auditor was David Bartlett, FCA , for and on behalf of Daly, Hoggett & Co. .

11. Controlling party

The company's holding company is Dr Schutz GmbH, a company incorporated in Germany. The company's ultimate holding company is Blanchon S.A., a company incorporated in France.